Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Non-Current Debt (2016 - 2025)

U S Physical Therapy's Non-Current Debt history spans 12 years, with the latest figure at $2.0 million for Q3 2023.

  • For Q3 2023, Non-Current Debt changed N/A year-over-year to $2.0 million; the TTM value through Sep 2023 reached $2.0 million, changed N/A, while the annual FY2022 figure was $142.9 million, 25.37% up from the prior year.
  • Non-Current Debt for Q3 2023 was $2.0 million at U S Physical Therapy, down from $142.1 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $144.6 million in Q2 2022 and bottomed at $509000.0 in Q3 2020.
  • The 5-year median for Non-Current Debt is $16.0 million (2020), against an average of $53.3 million.
  • The largest YoY upside for Non-Current Debt was 21993.02% in 2020 against a maximum downside of 99.0% in 2020.
  • A 5-year view of Non-Current Debt shows it stood at $4.4 million in 2019, then skyrocketed by 266.89% to $16.0 million in 2020, then soared by 612.5% to $114.0 million in 2021, then grew by 25.37% to $142.9 million in 2022, then tumbled by 98.57% to $2.0 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Non-Current Debt are $2.0 million (Q3 2023), $142.1 million (Q1 2023), and $142.9 million (Q4 2022).